8-KOther EventsExhibits & Filings

CARDINAL HEALTH INC 8-K Report, Corporate Update (Sep 25, 2009)

Filed September 25, 2009For Securities:CAH

Summary

This 8-K filing by Cardinal Health, Inc. (CAH) on September 25, 2009, reports the expiration and final results of a significant cash tender offer for its debt securities. The company aimed to purchase up to $1.2 billion in aggregate principal amount of various debentures and notes across different maturity dates and interest rates, including those issued by its wholly owned subsidiary, Allegiance Corporation. This action suggests a proactive approach by Cardinal Health to manage its capital structure and potentially refinance or reduce its outstanding debt. Investors should note this event as it reflects the company's strategy in managing its financial obligations and could have implications for its leverage profile and future interest expenses.

Key Highlights

  • 1Cardinal Health announced the expiration and final results of a cash tender offer for its debt securities.
  • 2The company intended to purchase up to $1.2 billion in aggregate principal amount of debt.
  • 3The tender offer included various debentures and notes with different maturity dates and interest rates.
  • 4Securities from Cardinal Health and its wholly owned subsidiary, Allegiance Corporation, were part of the offer.
  • 5This filing indicates a strategic move by Cardinal Health to manage its debt obligations.
  • 6The event highlights the company's focus on capital structure management and debt reduction.

Frequently Asked Questions

The primary purpose of the tender offer was for Cardinal Health to purchase up to $1.2 billion of its outstanding debt securities. This is a common strategy for companies to manage their debt profile, potentially refinancing at lower interest rates or reducing overall leverage.

The tender offer included several series of debt securities, including 7.80% Debentures due 2016 and 7.00% Debentures due 2026 from Allegiance Corporation, and various notes from Cardinal Health itself with interest rates ranging from 4.00% to 6.75% and maturity dates spanning from 2011 to 2017.

This tender offer suggests that Cardinal Health was actively managing its balance sheet and debt obligations. It could indicate a favorable view of the company's own debt, a desire to reduce interest expenses, or a strategic repositioning of its capital structure. The success of the offer, with a specified aggregate purchase price limit, implies the company had the liquidity or financing in place to execute this.

The filing states the 'aggregate purchase price, excluding accrued interest, fees and expenses, of up to $1,200,000,000', and announces the 'final results'. However, the specific amount repurchased is detailed in the accompanying news release (Exhibit 99.1), which is not fully provided in this text excerpt.